Yifan Pharmaceutical
China - HangzhouPharmaceutical
Focus: Yifan Pharmaceutical is a China-based innovator spanning oncology, biosimilars, generics, synthetic biologics, and traditional Chinese medicine formulations. The company operates from Hangzhou with a diversified therapeutic portfolio but currently shows minimal active development momentum.
Profile data last refreshed 10h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Yifan Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Yifan Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Yifan Pharmaceutical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Forsteo®
Healthy VolunteersRealgar-Indigo Naturalis Formulation Combined with Anlotinib
Platinum-resistant Ovarian Cancer (PROC)Clinical Trials (1)
Help build intelligence for Yifan Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.